CRYSTODIGIN (DIGITOXIN) — FDA Approval ANDA084100 (LILLY)
CRYSTODIGIN (DIGITOXIN) — FDA Approval ANDA084100 (LILLY) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CRYSTODIGIN; Active ingredients: DIGITOXIN; Application number: ANDA084100.
| Brand name | CRYSTODIGIN |
|---|---|
| Active ingredients | DIGITOXIN |
| Application number | ANDA084100 |
| Sponsor | LILLY |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19780828 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →